Targeting CDK9 for treatment of colorectal cancer

Targeting CDK9 for treatment of colorectal cancer

Colorectal cancer (CRC) remains one of the most lethal human malignancies, and pursuit of new therapeutic targets for treatment has been a major research focus. Cyclin‐dependent kinase 9 (CDK9), which plays a crucial role in transcription, has emerged as a target for cancer treatment. CDKI‐73, one o...

Full description

Bibliographic Details
Main Authors: Muhammed H. Rahaman, Frankie Lam, Longjin Zhong, Theodosia Teo, Julian Adams, Mingfeng Yu, Robert W. Milne, Chris Pepper, Noor A. Lokman, Carmela Ricciardelli, Martin K. Oehler, Shudong Wang
Format: Article
Language:English
Published: Wiley 2019-10-01
Series:Molecular Oncology
Subjects:
anti‐proliferation
apoptosis
cancer therapy
CDK9
colorectal cancer
RNAPII transcription
Online Access:https://doi.org/10.1002/1878-0261.12559

Internet

https://doi.org/10.1002/1878-0261.12559

Similar Items